DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence
- Staff Reporter
DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence
DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence